The global generic drugs market revenue was around US$ 416.5 billion in 2023 and is estimated to reach US$ 839.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.1% during the ...

We are now seeing more and more generics for “extended-release” drugs, i.e., diltiazem XT, metformin ER, and others. Can we rely on these to be pharmacokinetically equivalent to the original ...

Generic drugs have saved billions of dollars and benefited countless lives by making existing medicines more affordable. But a new study finds these drug copies may not all be created equal. Despite ...

COLUMBUS, Ohio – Generic drugs manufactured in India are linked to significantly more “severe adverse events” for patients who use them than equivalent drugs produced in the United States, a new study ...

Global & regional market size forecasts through 2035. Competitive benchmarking and SWOT analysis of top providers. Segmentation insights. Regulatory and sustainability landscape ...

Ropinirole belongs to a class of drugs known as a non-ergoline dopamine agonist used to treat symptoms of Parkinson's disease ...

Conflicts are intensifying among doctors, pharmacists, and the government over the introduction of generic name prescriptions ...

Prescription drug prices in the United States remain a major financial burden for millions of Americans. As healthcare costs rise and insurance coverage becomes increasingly complex, patients are ...

Attorney General Roy Cooper announced Friday that a major pharmaceutical manufacturer has agreed to stop blocking consumers' access to generic drugs and to pay refunds to consumers. North Carolina ...

The Food and Drug Monitoring Agency (BPOM) has issued the first generic drug permit in Indonesia containing dydrogesterone.